Coherus BioSciences laying off 20% of employees

Mar. 09, 2023 11:49 AM ETCoherus BioSciences, Inc. (CHRS)By: Jonathan Block, SA News Editor

Top view of notebook, pen and memo note written with text DOWNSIZING.

Abu Hanifah

  • Coherus BioSciences (NASDAQ:CHRS) will lay off 20% of its workforce -- about 60 full-time and part-time employees -- on Friday.
  • The biotech said the cuts would allow it to focus resources on strategic priorities such as commercialization of its product portfolio and development of its immuno-oncology pipeline.
  • The disclosure came in the biotech's latest 10-K filing.
  • In its Q4 earnings report released on Monday, Coherus (CHRS) beat on the bottom line but missed on the top.

Recommended For You

Comments

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.